Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Orthovita, Inc. - VITA
18 5월 2011 - 5:00AM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Orthovita, Inc. (“Orthovita” or the “Company”)
(NasdaqGM: VITA) for potential breaches of fiduciary duties in
connection with their conduct related to the sale of the Company to
Stryker Corp. (NYSE: SYK) for about $304 million in cash. The
proposed transaction offers Orthovita shareholders $3.85 per share.
According to Yahoo! Finance, at least one financial analyst has a
price target of $4 for Orthovita.
Request more information now by clicking here:
www.faruqilaw.com/VITA
Whether the Orthovita’s Board of Directors breached their
fiduciary duties to Orthovita’s stockholders by failing to conduct
an adequate and fair sales process to sell the Company prior to
agreeing to this proposed transaction, whether the proposed
transaction undervalues Orthovita’s shares and by how much this
proposed transaction undervalues the Company to the detriment of
Orthovita shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Orthovita and wish to obtain
additional information, please visit us at www.faruqilaw.com/VITA
or contact Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Orthovita, Inc. (MM) (NASDAQ:VITA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Orthovita, Inc. (MM) (NASDAQ:VITA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Orthovita, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Faruqi & Faruqi, LLP News Articles